Berthold Henglein
Research Subjects
Berthold Henglein has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Christine Lagorce-Pagès
1 shared publication- Diana Dudziak
Laboratory of Dendritic Cell Biology, Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University of Erlangen-Nürnberg
1 shared publication Franck Pagès
Institut National de la Santé et de la Recherche Médicale (INSERM) U255, Centre de Recherche Biomédicale des Cordeliers, Paris, France
1 shared publicationGalina Karaschuk
1 shared publicationGerhard Laux
1 shared publication- Jérôme Galon
INSERM, Laboratory of Integrative Cancer Immunology, Paris, France
1 shared publication
Latest Publications
- Open Access
- 15 February 2005
- Published by American Society of Hematology in Blood
- Vol. 105 (4) , 1632-1639
Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells
Epstein-Barr virus (EBV) latently infects and immortalizes B lymphocytes and causes lymphoproliferative malignancies. We show here that the EBV nuclear antigen EBNA2 induces expression of the 2 chains of the interleukin-18 receptor (IL-18R) in Burkitt lymphoma (BL) cell lines and in nontransformed B cells. Activation of IL-18R expression by EBNA2 is independent of its interaction with the transcriptional repressor RBPJκ. It occurs in the absence of any other viral protein but requires de novo synthesis of cellular proteins. IL-18R induction is a highly specific function of EBNA2, because neither other EBV latent proteins nor the cellular proteins c-myc or Notch can exert this effect. Using cDNA microarray expression profiling, we find that the IL-18 receptor expressed in EBV-infected BL cells has signaling capacity, because IL-18 significantly modified gene expression. We report that EBNA2 expression is associated with IL-18R expression in vivo in EBV-positive B-lymphomas from AIDS patients. (Blood. 2005;105:1632-1639)
- 15 February 2005
- Published by American Society of Hematology in Blood
- Vol. 105 (4) , 1632-1639
Open AccessEpstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells
Epstein-Barr virus (EBV) latently infects and immortalizes B lymphocytes and causes lymphoproliferative malignancies. We show here that the EBV nuclear antigen EBNA2 induces expression of the 2 chains of the interleukin-18 receptor (IL-18R) in Burkitt lymphoma (BL) cell lines and in nontransformed B cells. Activation of IL-18R expression by EBNA2 is independent of its interaction with the transcriptional repressor RBPJκ. It occurs in the absence of any other viral protein but requires de novo synthesis of cellular proteins. IL-18R induction is a highly specific function of EBNA2, because neither other EBV latent proteins nor the cellular proteins c-myc or Notch can exert this effect. Using cDNA microarray expression profiling, we find that the IL-18 receptor expressed in EBV-infected BL cells has signaling capacity, because IL-18 significantly modified gene expression. We report that EBNA2 expression is associated with IL-18R expression in vivo in EBV-positive B-lymphomas from AIDS patients. (Blood. 2005;105:1632-1639)